NASDAQ:GPCR | Cash Flow Statement | Structure Therapeutics Inc.

Complete source-backed cash-flow history.

Available history
2022-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$106.16M
2026-03-31-$75.97M$15.23M$1.18M-$496.95M-$1.74M
2025-12-31$33M-$64.42M$1.5M$56.14M$704.99M
2025-09-30-$65.71M
2025-06-30-$61.66M
2025-03-31-$46.83M-$52.23M$314,000.00$34.03M$809,000.00
2024-12-31-$36.48M-$36.47M$16,000.00$33.23M$615,000.00
2024-09-30-$33.98M
2024-06-30-$26.03M
2024-03-31-$26.04M-$34.08M$162,000.00$1.42M$702,000.00
2023-12-31-$24.5M-$21.73M$1.16M-$180.74M$281.63M
2023-09-30-$23.86M
2023-06-30-$23.28M
2023-03-31-$17.98M-$20.31M-$49.02M$169.73M
2022-12-31-$11.88M-$12.03M$71,000.00$10.34M-$316,000.00
2022-09-30-$12.42M
2022-06-30-$13.95M
2022-03-31-$13.08M-$13.52M$65,000.00-$39.72M-$1.45M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$141.2M-$222.2M$3.61M$89.8M$762.52M
2024-12-31-$122.53M-$116.64M$1.29M-$358.91M$515.26M
2023-12-31-$89.62M-$79.49M$2.17M-$268.34M$451.53M
2022-12-31-$51.32M-$46.12M$155,000.00-$62.11M$29.01M